SlideShare a Scribd company logo
ExercisePrescriptionFor
HypertensivePopulation
Dr. Shilpasree Saha (PT),
BPT, MPT (Cardio-Thoracic Disorders)
Content
 Hypertension.
 Stages/Grades of Hypertension.
 Health care burden!!!
 What is the answer of this burden?
 Physical activity & Exercise.
 PA, exercise and prevention of HTN.
 Antihypertensive effects of exercise.
Hypertension
 Hypertension is the most common, costly, and
preventable cardiovascular disease (CVD) risk factor.
 The current definition of hypertension (HTN) is systolic
blood pressure (SBP) values of 130mmHg or more
and/or diastolic blood pressure (DBP) more than 80
mmHg. *
 Prevalence of hypertension in India is at alarming level
and is estimated to account for 10.8% of all the deaths
in the country.**
*Iqbal AM, Jamal SF. Essential Hypertension. [Updated 2022 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-.
Available from: https://www.ncbi.nlm.nih.gov/books/NBK539859/
**Kurjogi MM, Vanti GL, Kaulgud RS. Prevalence of hypertension and its associated risk factors in Dharwad population: A cross-sectional study.
Indian Heart J. 2021 Nov-Dec;73(6):751-753.doi: 10.1016/j.ihj.2021.10.006.Epub 2021 Oct 22. PMID: 34695447;PMCID: PMC8642654.
Stages/Grades American College of
Cardiology (ACC)
guidelines
ESC/ESH guidelines
Optimal SBP less than 120mmHg
and DBP less than
80mmHg
Normal SBP less than 120 and DBP
less than 80mmHg
SBP 120 to 129mmHg
and/or DBP 80 to 84mmHg
Elevated/ Highly
normal
SBP 120 to 129 and DBP less
than 80mmHg
SBP 130 to 139mmHg
and/or DBP 85 to 89mmHg
Stage 1/Grade 1 SBP 130 to 139 or DBP 80 to
89mmHg
SBP 140 to 159mmHg
and/or DBP 90 to 99mmHg
Stage 2/Grade 2 SBP greater than or equal to
140 mmHg or greater than
or equal to 90 mmHg
SBP 160 to 179mmHg
and/or DBP 100 to
109mmHg
Grade 3 SBP greater than or equal
to 180mmHg and/or DBP
greater than or equal to
110mmHg
Isolated systolic
hypertension
SBP greater than or equal
to 140mmHg and DBP less
than 90mmHg
Stages/Grades
ofHypertension
Healthcare
burden!!!
 Hypertension (HTN) is estimated to have caused 9.4
million deaths and third cause of disability-adjusted life
years worldwide.
 The global prevalence of HTN in >18 years old was ~
22% in 2014.
 Uncontrolled HTN causes stroke, myocardial infarction,
cardiac failure, dementia, renal failure and blindness;
causing human suffering and imposing severe financial
and service burdens on the health system.
WHO. Global status report on noncommunicable diseases 2014. Geneva : World Health Organization. 2014. Available
from:http://www.who.int/nmh/publications/ncd-status-report-2014/en/
Whatis the
answerofthis
burden?
 Because of the high prevalence,drug treatment can be
costly and is a challenge for resource-constrained settings.
 The only solution is to control hypertension using an
affordable total-risk approach, and concurrently take
action to reduce its incidence.
 One of the measures that are needed to attain this target is
physical activity; hence WHO has set the goal of a 10%
reduction in physical inactivity and 25% reduction in
hypertension by 2020.
 Lifestyle factors,such as participation in regular exercise,
are recognized as key modifiable determinants of
hypertension.
 Therefore,there is a need for more intensive efforts to
promote strategies to reduce the significant public health
burden of hypertension
 Epidemiologic studies suggest that the relationship
between sedentary behaviour and HTN is so strong that
the National Heart Foundation, World Health
Organisation, International Society of Hypertension,
United States Joint National Committee on Detection,
Evaluation and Treatment of High Blood Pressure, and
American College of Sports Medicine have all
recommended increased physical activity as a first line
intervention for preventing and treating patients with
preHTN and HTN
Baster T, Baster-Brooks C. Exercise and hypertension. Aust Fam Physician. 2005 Jun;34(6):419-24.
Physicalactivity
&
Exercise
 Physical activity (PA) is defined as any bodily
movement produced by contraction of skeletal muscles
that increases energy expenditure above resting levels
and comprises routine daily tasks.
 Exercise is a component of physical activity that is
planned, structured, and repetitive with the intent of
improving or maintaining health.
PA,exerciseand
preventionof
HTN
 ↓ Vascular Resistance
 ↓ Arterial Stiffness
 ↓ Oxidative Stress
 ↓ Inflammation
 ↓ Body Weight/Body Mass
 ↓ Sympathetic Activity
 ↓ Renin-angiotensin System
Activity
 ↓ Intima-media thickness
 ↓ Vascular responsiveness to
adrenergic- and endothelin-
receptor stimulation
 ↑ Arterial lumen diameter
 ↑ Endothelial Function
 ↑ Insulin
Sensitivity/Glucose
Handling
 ↑ Renal Function
 ↑ Sodium Handling
 ↑ Baroreflex Sensitivity
 ↑ Parasympathetic
Activity
 ↑ Angiogenesis
 ↑ Arterial Compliance
 ↓ Psychosocial Stress
 ↑ Arteriogenesis
Antihypertensive
effectsof
exercise
 Aerobic exercise training lowers blood pressure (BP) 5–
7 mmHg, while dynamic resistance training lowers BP 2–
3 mmHg among adults with hypertension.
 Exercising as little as 1 day per week is as effective (or
even more so) than pharmacotherapy for reducing all-
cause mortality among those with hypertension.
Baster T, Baster-Brooks C. Exercise and hypertension. Aust Fam Physician. 2005 Jun;34(6):419-24.
Brooks JH, Ferro A. The physician's role in prescribing physical activity for the prevention and treatment of essential hypertension. JRSM Cardiovasc Dis. 2012
Jul 31;1(4). pii: cvd.2012.012012.
AnExercise
Prescriptionfor
Hypertension
 Frequency: Aerobic exercise on most, preferably all
days of the week and dynamic resistance exercise on 2
to 3 days in that same week.
 Intensity: Moderate intensity aerobic exercise (i.e., 40 to
<60 % VO2max or HR reserve; 11–13 rating of
perceived exertion [RPE] on the 6–20 Borg Scale and
moderate intensity dynamic resistance exercise (60 %
to 80 % one repetition maximum [1-RM]).
Time: Aerobic exercise should be performed for 30
to 60 min per day. Dynamic resistance exercise
should consist of two to three sets of 10 to 12
repetitions for 8 to 10 exercises that target the
major muscle groups of the upper and lower body.
The duration of exercise should total 150 min or
more per week.
Type: Examples of aerobic activities may include
walking, jogging, cycling, and swimming. Dynamic
resistance training equipment may include
machine weights, free weights, and resistance
bands, as well as functional body weight exercises.
 Endothelial progenitor cells (EPCs) play an important
role in repairing vascular injury and can be classified
into early and late EPCs.
 Late EPCs have been recognized as endogenous cells
involved in de novo blood vessel formation. In
hypertension, increased peripheral vascular resistance
results from vascular dysfunction with MVR
(microvascular rarefaction) which is related to late EPC
angiogenesis ability.
 Exercise is a promising way to increase EPC function,
however, the fall in angiogenic capacity of late EPCs is
correlated with MVR in hypertension.
Medical status
Preparticipation screening and
physical activity advice
1
Asymptomatic, low CVD risk
and BP <140/90 mmHg
Routine evaluation and self-
directed physical activity
2
Asymptomatic, low CVD risk
and hypertensive ≥140/90
mmHg
Routine evaluation and begin with
moderate intensity exercise (<60%
heart rate reserve)
3
Asymptomatic, high CVD
risk and hypertensive
≥140/90 mmHg
Symptomatic exercise testing prior
to start (for example, ECG exercise
test)
4 Symptomatic CVD
Medical supervision during
exercise initially
Recommendations regarding exercise testing for individuals with HTN vary
depending on their BP level and the presence of other CVD risk factors, target
organ disease, or clinical CVD
Exercise Prescription For Hypertensive Population.pdf

More Related Content

What's hot

IPPB
IPPBIPPB
Neurodynamics- I
Neurodynamics- INeurodynamics- I
Neurodynamics- I
Radhika Chintamani
 
Incremental shuttle walking test
Incremental shuttle walking testIncremental shuttle walking test
Incremental shuttle walking test
Dr Amolkumar W Diwan
 
Exercise prescription in diabetes mellitus
Exercise prescription in diabetes mellitusExercise prescription in diabetes mellitus
Exercise prescription in diabetes mellitus
Dr Amrit Parihar
 
Exercise tolerance testing
Exercise tolerance testingExercise tolerance testing
Exercise tolerance testing
Physioaadhar Physiotherapy Services
 
Pt assessment
Pt assessment Pt assessment
Pt assessment
BPT4thyearJamiaMilli
 
Active Cycle of Breathing Technique (ACBT)
Active Cycle of Breathing Technique (ACBT)Active Cycle of Breathing Technique (ACBT)
Active Cycle of Breathing Technique (ACBT)
Sunil kumar
 
Neural tissue mobilization
Neural tissue mobilizationNeural tissue mobilization
Flutter a device for clearance of airway
Flutter  a device for clearance of airwayFlutter  a device for clearance of airway
Flutter a device for clearance of airway
Shilpasree Saha
 
Mc Kenzie Method (MDT)
Mc Kenzie Method  (MDT)Mc Kenzie Method  (MDT)
Mc Kenzie Method (MDT)
Sreeraj S R
 
Roods approach
Roods approachRoods approach
Roods approach
Muskan Rastogi
 
Mannual hyperinflation
Mannual hyperinflationMannual hyperinflation
Mannual hyperinflation
Sunil kumar
 
Physical Therapy Management of Patients with Diabetes
Physical Therapy Management of Patients with DiabetesPhysical Therapy Management of Patients with Diabetes
Physical Therapy Management of Patients with Diabetes
Kyle Veazey
 
Principles of exercise prescription
Principles of exercise prescription   Principles of exercise prescription
Principles of exercise prescription
Apeksha Pahade
 
Chest mobilization exercises, Butterfly Technique
Chest mobilization exercises, Butterfly TechniqueChest mobilization exercises, Butterfly Technique
Chest mobilization exercises, Butterfly Technique
Sunil kumar
 
Spasticity management
Spasticity managementSpasticity management
Spasticity management
JWANIKA VANSIYA
 
MET: Muscle Energy Technique
MET: Muscle Energy TechniqueMET: Muscle Energy Technique
MET: Muscle Energy Technique
Radhika Chintamani
 
Assessment of balance
Assessment of balanceAssessment of balance
Assessment of balance
Odeyoyin Yusuph Abiodun
 
Hypertension and exercise
Hypertension and exerciseHypertension and exercise
Hypertension and exercise
Asyhera Asleh
 
Autogenic drainage
Autogenic drainageAutogenic drainage
Autogenic drainage
BPT4thyearJamiaMilli
 

What's hot (20)

IPPB
IPPBIPPB
IPPB
 
Neurodynamics- I
Neurodynamics- INeurodynamics- I
Neurodynamics- I
 
Incremental shuttle walking test
Incremental shuttle walking testIncremental shuttle walking test
Incremental shuttle walking test
 
Exercise prescription in diabetes mellitus
Exercise prescription in diabetes mellitusExercise prescription in diabetes mellitus
Exercise prescription in diabetes mellitus
 
Exercise tolerance testing
Exercise tolerance testingExercise tolerance testing
Exercise tolerance testing
 
Pt assessment
Pt assessment Pt assessment
Pt assessment
 
Active Cycle of Breathing Technique (ACBT)
Active Cycle of Breathing Technique (ACBT)Active Cycle of Breathing Technique (ACBT)
Active Cycle of Breathing Technique (ACBT)
 
Neural tissue mobilization
Neural tissue mobilizationNeural tissue mobilization
Neural tissue mobilization
 
Flutter a device for clearance of airway
Flutter  a device for clearance of airwayFlutter  a device for clearance of airway
Flutter a device for clearance of airway
 
Mc Kenzie Method (MDT)
Mc Kenzie Method  (MDT)Mc Kenzie Method  (MDT)
Mc Kenzie Method (MDT)
 
Roods approach
Roods approachRoods approach
Roods approach
 
Mannual hyperinflation
Mannual hyperinflationMannual hyperinflation
Mannual hyperinflation
 
Physical Therapy Management of Patients with Diabetes
Physical Therapy Management of Patients with DiabetesPhysical Therapy Management of Patients with Diabetes
Physical Therapy Management of Patients with Diabetes
 
Principles of exercise prescription
Principles of exercise prescription   Principles of exercise prescription
Principles of exercise prescription
 
Chest mobilization exercises, Butterfly Technique
Chest mobilization exercises, Butterfly TechniqueChest mobilization exercises, Butterfly Technique
Chest mobilization exercises, Butterfly Technique
 
Spasticity management
Spasticity managementSpasticity management
Spasticity management
 
MET: Muscle Energy Technique
MET: Muscle Energy TechniqueMET: Muscle Energy Technique
MET: Muscle Energy Technique
 
Assessment of balance
Assessment of balanceAssessment of balance
Assessment of balance
 
Hypertension and exercise
Hypertension and exerciseHypertension and exercise
Hypertension and exercise
 
Autogenic drainage
Autogenic drainageAutogenic drainage
Autogenic drainage
 

Similar to Exercise Prescription For Hypertensive Population.pdf

International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)
inventionjournals
 
Cardiovascular Diseases and Physical Education
Cardiovascular Diseases and Physical EducationCardiovascular Diseases and Physical Education
Cardiovascular Diseases and Physical Education
michaeltunggay14
 
Exercise as a prescriptive medicine in Non Communicable Diseases
Exercise as a prescriptive medicine in Non Communicable Diseases Exercise as a prescriptive medicine in Non Communicable Diseases
Exercise as a prescriptive medicine in Non Communicable Diseases
Tinuade Olarewaju
 
To Assess the Effect of Body Mass Index on Cardiac Efficiency in Adolescent B...
To Assess the Effect of Body Mass Index on Cardiac Efficiency in Adolescent B...To Assess the Effect of Body Mass Index on Cardiac Efficiency in Adolescent B...
To Assess the Effect of Body Mass Index on Cardiac Efficiency in Adolescent B...
iosrjce
 
Seminar presentation 8
Seminar presentation 8Seminar presentation 8
Seminar presentation 8
SumaiyaShams
 
Coronary Heart Disease and Exercise: What's the evidence?
Coronary Heart Disease and Exercise: What's the evidence?Coronary Heart Disease and Exercise: What's the evidence?
Coronary Heart Disease and Exercise: What's the evidence?
Yeong Yeh Lee
 
SPORTS MEDICINE SEMINAR PRESENTATION NDUTH RESIDENCY.pptx
SPORTS MEDICINE SEMINAR PRESENTATION NDUTH RESIDENCY.pptxSPORTS MEDICINE SEMINAR PRESENTATION NDUTH RESIDENCY.pptx
SPORTS MEDICINE SEMINAR PRESENTATION NDUTH RESIDENCY.pptx
daughter awala
 
Tmt Seminary
Tmt SeminaryTmt Seminary
Tmt Seminary
pravinpawal
 
Tmt Seminary
Tmt SeminaryTmt Seminary
Contraversies in hypertension management
Contraversies in hypertension managementContraversies in hypertension management
Contraversies in hypertension management
Shyam Jadhav
 
Fitness and health
Fitness and healthFitness and health
Fitness and health
Malik Ibrahim
 
Ijpr.2016.129
Ijpr.2016.129Ijpr.2016.129
Ijpr.2016.129
prabhakaran natraj
 
Optimizing Outcomes in Cardiac Rehabilitation The Importance of Exercise Inte...
Optimizing Outcomes in Cardiac Rehabilitation The Importance of Exercise Inte...Optimizing Outcomes in Cardiac Rehabilitation The Importance of Exercise Inte...
Optimizing Outcomes in Cardiac Rehabilitation The Importance of Exercise Inte...
ssuser4701fb
 
The Elderly With Heart Disease internship project
The Elderly With Heart Disease internship projectThe Elderly With Heart Disease internship project
The Elderly With Heart Disease internship project
jinyeob kim
 
BFRT
BFRTBFRT
Exercise in Primary Care
Exercise in Primary CareExercise in Primary Care
Exercise in Primary Care
Jordan Feigenbaum
 
CARDIO docx
CARDIO docxCARDIO docx
CARDIO docx
JamilaBullan
 
Myths and legacy of exercisemedicine in chronic diseases
Myths and legacy of exercisemedicine in chronic diseasesMyths and legacy of exercisemedicine in chronic diseases
Myths and legacy of exercisemedicine in chronic diseases
Ann Gates
 
Special population presentations day 3
Special population presentations day 3Special population presentations day 3
Special population presentations day 3
Leesah Mapa
 
Exercise and health part 3
Exercise and health part 3Exercise and health part 3
Exercise and health part 3
fathi neana
 

Similar to Exercise Prescription For Hypertensive Population.pdf (20)

International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)International Journal of Pharmaceutical Science Invention (IJPSI)
International Journal of Pharmaceutical Science Invention (IJPSI)
 
Cardiovascular Diseases and Physical Education
Cardiovascular Diseases and Physical EducationCardiovascular Diseases and Physical Education
Cardiovascular Diseases and Physical Education
 
Exercise as a prescriptive medicine in Non Communicable Diseases
Exercise as a prescriptive medicine in Non Communicable Diseases Exercise as a prescriptive medicine in Non Communicable Diseases
Exercise as a prescriptive medicine in Non Communicable Diseases
 
To Assess the Effect of Body Mass Index on Cardiac Efficiency in Adolescent B...
To Assess the Effect of Body Mass Index on Cardiac Efficiency in Adolescent B...To Assess the Effect of Body Mass Index on Cardiac Efficiency in Adolescent B...
To Assess the Effect of Body Mass Index on Cardiac Efficiency in Adolescent B...
 
Seminar presentation 8
Seminar presentation 8Seminar presentation 8
Seminar presentation 8
 
Coronary Heart Disease and Exercise: What's the evidence?
Coronary Heart Disease and Exercise: What's the evidence?Coronary Heart Disease and Exercise: What's the evidence?
Coronary Heart Disease and Exercise: What's the evidence?
 
SPORTS MEDICINE SEMINAR PRESENTATION NDUTH RESIDENCY.pptx
SPORTS MEDICINE SEMINAR PRESENTATION NDUTH RESIDENCY.pptxSPORTS MEDICINE SEMINAR PRESENTATION NDUTH RESIDENCY.pptx
SPORTS MEDICINE SEMINAR PRESENTATION NDUTH RESIDENCY.pptx
 
Tmt Seminary
Tmt SeminaryTmt Seminary
Tmt Seminary
 
Tmt Seminary
Tmt SeminaryTmt Seminary
Tmt Seminary
 
Contraversies in hypertension management
Contraversies in hypertension managementContraversies in hypertension management
Contraversies in hypertension management
 
Fitness and health
Fitness and healthFitness and health
Fitness and health
 
Ijpr.2016.129
Ijpr.2016.129Ijpr.2016.129
Ijpr.2016.129
 
Optimizing Outcomes in Cardiac Rehabilitation The Importance of Exercise Inte...
Optimizing Outcomes in Cardiac Rehabilitation The Importance of Exercise Inte...Optimizing Outcomes in Cardiac Rehabilitation The Importance of Exercise Inte...
Optimizing Outcomes in Cardiac Rehabilitation The Importance of Exercise Inte...
 
The Elderly With Heart Disease internship project
The Elderly With Heart Disease internship projectThe Elderly With Heart Disease internship project
The Elderly With Heart Disease internship project
 
BFRT
BFRTBFRT
BFRT
 
Exercise in Primary Care
Exercise in Primary CareExercise in Primary Care
Exercise in Primary Care
 
CARDIO docx
CARDIO docxCARDIO docx
CARDIO docx
 
Myths and legacy of exercisemedicine in chronic diseases
Myths and legacy of exercisemedicine in chronic diseasesMyths and legacy of exercisemedicine in chronic diseases
Myths and legacy of exercisemedicine in chronic diseases
 
Special population presentations day 3
Special population presentations day 3Special population presentations day 3
Special population presentations day 3
 
Exercise and health part 3
Exercise and health part 3Exercise and health part 3
Exercise and health part 3
 

More from Shilpasree Saha

Intercostal drainage.pptx
Intercostal drainage.pptxIntercostal drainage.pptx
Intercostal drainage.pptx
Shilpasree Saha
 
ASTHMA and it's Physiotherapy Treatment.pptx
ASTHMA  and it's Physiotherapy Treatment.pptxASTHMA  and it's Physiotherapy Treatment.pptx
ASTHMA and it's Physiotherapy Treatment.pptx
Shilpasree Saha
 
Pneumothorax and Physiotherapy management .pptx
Pneumothorax and Physiotherapy management .pptxPneumothorax and Physiotherapy management .pptx
Pneumothorax and Physiotherapy management .pptx
Shilpasree Saha
 
Physiotherapy in pulmonary_surgery[1].pptx
Physiotherapy in pulmonary_surgery[1].pptxPhysiotherapy in pulmonary_surgery[1].pptx
Physiotherapy in pulmonary_surgery[1].pptx
Shilpasree Saha
 
INCENTIVE SPIROMETER (1).pptx
INCENTIVE SPIROMETER (1).pptxINCENTIVE SPIROMETER (1).pptx
INCENTIVE SPIROMETER (1).pptx
Shilpasree Saha
 
Peripheral Arterial Disease.pptx
Peripheral Arterial Disease.pptxPeripheral Arterial Disease.pptx
Peripheral Arterial Disease.pptx
Shilpasree Saha
 
Respiratory Infections in Children.pptx
Respiratory Infections in Children.pptxRespiratory Infections in Children.pptx
Respiratory Infections in Children.pptx
Shilpasree Saha
 
CARCINOMA OF RESPIRATOTY TRACT.pptx
CARCINOMA OF RESPIRATOTY TRACT.pptxCARCINOMA OF RESPIRATOTY TRACT.pptx
CARCINOMA OF RESPIRATOTY TRACT.pptx
Shilpasree Saha
 
Stress Management in Sports.pptx
Stress Management in Sports.pptxStress Management in Sports.pptx
Stress Management in Sports.pptx
Shilpasree Saha
 
REHABILITATION FOR ORTHOSTATIC HYPOTENSION.pptx
REHABILITATION FOR ORTHOSTATIC HYPOTENSION.pptxREHABILITATION FOR ORTHOSTATIC HYPOTENSION.pptx
REHABILITATION FOR ORTHOSTATIC HYPOTENSION.pptx
Shilpasree Saha
 
Pneumothorax.pptx
Pneumothorax.pptxPneumothorax.pptx
Pneumothorax.pptx
Shilpasree Saha
 
ARTERIAL BLOOD GAS ANALYSIS (1).pptx
ARTERIAL BLOOD GAS ANALYSIS (1).pptxARTERIAL BLOOD GAS ANALYSIS (1).pptx
ARTERIAL BLOOD GAS ANALYSIS (1).pptx
Shilpasree Saha
 
Humidification & Nebulization.pptx
Humidification & Nebulization.pptxHumidification & Nebulization.pptx
Humidification & Nebulization.pptx
Shilpasree Saha
 
ABNORMAL ECG PART-2: CONDUCTION DIFFICULTY .
ABNORMAL ECG PART-2: CONDUCTION DIFFICULTY . ABNORMAL ECG PART-2: CONDUCTION DIFFICULTY .
ABNORMAL ECG PART-2: CONDUCTION DIFFICULTY .
Shilpasree Saha
 
Abnormal ECG- Arhythmia.pptx
Abnormal ECG- Arhythmia.pptxAbnormal ECG- Arhythmia.pptx
Abnormal ECG- Arhythmia.pptx
Shilpasree Saha
 
Valvular Heart Disease.pptx
Valvular Heart Disease.pptxValvular Heart Disease.pptx
Valvular Heart Disease.pptx
Shilpasree Saha
 
Exercise Prescription for Women.pdf
Exercise Prescription for Women.pdfExercise Prescription for Women.pdf
Exercise Prescription for Women.pdf
Shilpasree Saha
 
PalpaTion Techniques- 1.pptx
PalpaTion Techniques- 1.pptxPalpaTion Techniques- 1.pptx
PalpaTion Techniques- 1.pptx
Shilpasree Saha
 
PULMONARY FUNCTION TEST.pdf
PULMONARY FUNCTION TEST.pdfPULMONARY FUNCTION TEST.pdf
PULMONARY FUNCTION TEST.pdf
Shilpasree Saha
 
diaphragm assessment.pdf
diaphragm assessment.pdfdiaphragm assessment.pdf
diaphragm assessment.pdf
Shilpasree Saha
 

More from Shilpasree Saha (20)

Intercostal drainage.pptx
Intercostal drainage.pptxIntercostal drainage.pptx
Intercostal drainage.pptx
 
ASTHMA and it's Physiotherapy Treatment.pptx
ASTHMA  and it's Physiotherapy Treatment.pptxASTHMA  and it's Physiotherapy Treatment.pptx
ASTHMA and it's Physiotherapy Treatment.pptx
 
Pneumothorax and Physiotherapy management .pptx
Pneumothorax and Physiotherapy management .pptxPneumothorax and Physiotherapy management .pptx
Pneumothorax and Physiotherapy management .pptx
 
Physiotherapy in pulmonary_surgery[1].pptx
Physiotherapy in pulmonary_surgery[1].pptxPhysiotherapy in pulmonary_surgery[1].pptx
Physiotherapy in pulmonary_surgery[1].pptx
 
INCENTIVE SPIROMETER (1).pptx
INCENTIVE SPIROMETER (1).pptxINCENTIVE SPIROMETER (1).pptx
INCENTIVE SPIROMETER (1).pptx
 
Peripheral Arterial Disease.pptx
Peripheral Arterial Disease.pptxPeripheral Arterial Disease.pptx
Peripheral Arterial Disease.pptx
 
Respiratory Infections in Children.pptx
Respiratory Infections in Children.pptxRespiratory Infections in Children.pptx
Respiratory Infections in Children.pptx
 
CARCINOMA OF RESPIRATOTY TRACT.pptx
CARCINOMA OF RESPIRATOTY TRACT.pptxCARCINOMA OF RESPIRATOTY TRACT.pptx
CARCINOMA OF RESPIRATOTY TRACT.pptx
 
Stress Management in Sports.pptx
Stress Management in Sports.pptxStress Management in Sports.pptx
Stress Management in Sports.pptx
 
REHABILITATION FOR ORTHOSTATIC HYPOTENSION.pptx
REHABILITATION FOR ORTHOSTATIC HYPOTENSION.pptxREHABILITATION FOR ORTHOSTATIC HYPOTENSION.pptx
REHABILITATION FOR ORTHOSTATIC HYPOTENSION.pptx
 
Pneumothorax.pptx
Pneumothorax.pptxPneumothorax.pptx
Pneumothorax.pptx
 
ARTERIAL BLOOD GAS ANALYSIS (1).pptx
ARTERIAL BLOOD GAS ANALYSIS (1).pptxARTERIAL BLOOD GAS ANALYSIS (1).pptx
ARTERIAL BLOOD GAS ANALYSIS (1).pptx
 
Humidification & Nebulization.pptx
Humidification & Nebulization.pptxHumidification & Nebulization.pptx
Humidification & Nebulization.pptx
 
ABNORMAL ECG PART-2: CONDUCTION DIFFICULTY .
ABNORMAL ECG PART-2: CONDUCTION DIFFICULTY . ABNORMAL ECG PART-2: CONDUCTION DIFFICULTY .
ABNORMAL ECG PART-2: CONDUCTION DIFFICULTY .
 
Abnormal ECG- Arhythmia.pptx
Abnormal ECG- Arhythmia.pptxAbnormal ECG- Arhythmia.pptx
Abnormal ECG- Arhythmia.pptx
 
Valvular Heart Disease.pptx
Valvular Heart Disease.pptxValvular Heart Disease.pptx
Valvular Heart Disease.pptx
 
Exercise Prescription for Women.pdf
Exercise Prescription for Women.pdfExercise Prescription for Women.pdf
Exercise Prescription for Women.pdf
 
PalpaTion Techniques- 1.pptx
PalpaTion Techniques- 1.pptxPalpaTion Techniques- 1.pptx
PalpaTion Techniques- 1.pptx
 
PULMONARY FUNCTION TEST.pdf
PULMONARY FUNCTION TEST.pdfPULMONARY FUNCTION TEST.pdf
PULMONARY FUNCTION TEST.pdf
 
diaphragm assessment.pdf
diaphragm assessment.pdfdiaphragm assessment.pdf
diaphragm assessment.pdf
 

Recently uploaded

DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
anaghabharat01
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
KerlynIgnacio
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
ShraddhaTamshettiwar
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
LEFLOT Jean-Louis
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
DrGirishJHoogar
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
Traumasoft LLC
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
Dr.pavithra Anandan
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
Rahul Sen
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
SIVAVINAYAKPK
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Kosmoderma Academy Of Aesthetic Medicine
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
MuhammadMuneer49
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
Gokuldas Hospital
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
KULDEEP VYAS
 

Recently uploaded (20)

DECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principlesDECLARATION OF HELSINKI - History and principles
DECLARATION OF HELSINKI - History and principles
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
pharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdfpharmacology for dummies free pdf download.pdf
pharmacology for dummies free pdf download.pdf
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIESLOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
 
Cervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptxCervical Disc Arthroplasty ORSI 2024.pptx
Cervical Disc Arthroplasty ORSI 2024.pptx
 
Recent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptxRecent advances on Cervical cancer .pptx
Recent advances on Cervical cancer .pptx
 
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations   10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
 
vonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentationvonoprazan A novel drug for GERD presentation
vonoprazan A novel drug for GERD presentation
 
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdfNAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
NAVIGATING THE HORIZONS OF TIME LAPSE EMBRYO MONITORING.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Nano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory projectNano-gold for Cancer Therapy chemistry investigatory project
Nano-gold for Cancer Therapy chemistry investigatory project
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
 
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdfOphthalmic drugs latest. Xxxxxxzxxxxxx.pdf
Ophthalmic drugs latest. Xxxxxxzxxxxxx.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Skin Diseases That Happen During Summer.
 Skin Diseases That Happen During Summer. Skin Diseases That Happen During Summer.
Skin Diseases That Happen During Summer.
 
SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.SENSORY NEEDS B.SC. NURSING SEMESTER II.
SENSORY NEEDS B.SC. NURSING SEMESTER II.
 

Exercise Prescription For Hypertensive Population.pdf

  • 1. ExercisePrescriptionFor HypertensivePopulation Dr. Shilpasree Saha (PT), BPT, MPT (Cardio-Thoracic Disorders)
  • 2. Content  Hypertension.  Stages/Grades of Hypertension.  Health care burden!!!  What is the answer of this burden?  Physical activity & Exercise.  PA, exercise and prevention of HTN.  Antihypertensive effects of exercise.
  • 3. Hypertension  Hypertension is the most common, costly, and preventable cardiovascular disease (CVD) risk factor.  The current definition of hypertension (HTN) is systolic blood pressure (SBP) values of 130mmHg or more and/or diastolic blood pressure (DBP) more than 80 mmHg. *  Prevalence of hypertension in India is at alarming level and is estimated to account for 10.8% of all the deaths in the country.** *Iqbal AM, Jamal SF. Essential Hypertension. [Updated 2022 Jul 4]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK539859/ **Kurjogi MM, Vanti GL, Kaulgud RS. Prevalence of hypertension and its associated risk factors in Dharwad population: A cross-sectional study. Indian Heart J. 2021 Nov-Dec;73(6):751-753.doi: 10.1016/j.ihj.2021.10.006.Epub 2021 Oct 22. PMID: 34695447;PMCID: PMC8642654.
  • 4. Stages/Grades American College of Cardiology (ACC) guidelines ESC/ESH guidelines Optimal SBP less than 120mmHg and DBP less than 80mmHg Normal SBP less than 120 and DBP less than 80mmHg SBP 120 to 129mmHg and/or DBP 80 to 84mmHg Elevated/ Highly normal SBP 120 to 129 and DBP less than 80mmHg SBP 130 to 139mmHg and/or DBP 85 to 89mmHg Stage 1/Grade 1 SBP 130 to 139 or DBP 80 to 89mmHg SBP 140 to 159mmHg and/or DBP 90 to 99mmHg Stage 2/Grade 2 SBP greater than or equal to 140 mmHg or greater than or equal to 90 mmHg SBP 160 to 179mmHg and/or DBP 100 to 109mmHg Grade 3 SBP greater than or equal to 180mmHg and/or DBP greater than or equal to 110mmHg Isolated systolic hypertension SBP greater than or equal to 140mmHg and DBP less than 90mmHg Stages/Grades ofHypertension
  • 5. Healthcare burden!!!  Hypertension (HTN) is estimated to have caused 9.4 million deaths and third cause of disability-adjusted life years worldwide.  The global prevalence of HTN in >18 years old was ~ 22% in 2014.  Uncontrolled HTN causes stroke, myocardial infarction, cardiac failure, dementia, renal failure and blindness; causing human suffering and imposing severe financial and service burdens on the health system. WHO. Global status report on noncommunicable diseases 2014. Geneva : World Health Organization. 2014. Available from:http://www.who.int/nmh/publications/ncd-status-report-2014/en/
  • 6. Whatis the answerofthis burden?  Because of the high prevalence,drug treatment can be costly and is a challenge for resource-constrained settings.  The only solution is to control hypertension using an affordable total-risk approach, and concurrently take action to reduce its incidence.  One of the measures that are needed to attain this target is physical activity; hence WHO has set the goal of a 10% reduction in physical inactivity and 25% reduction in hypertension by 2020.  Lifestyle factors,such as participation in regular exercise, are recognized as key modifiable determinants of hypertension.  Therefore,there is a need for more intensive efforts to promote strategies to reduce the significant public health burden of hypertension
  • 7.  Epidemiologic studies suggest that the relationship between sedentary behaviour and HTN is so strong that the National Heart Foundation, World Health Organisation, International Society of Hypertension, United States Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure, and American College of Sports Medicine have all recommended increased physical activity as a first line intervention for preventing and treating patients with preHTN and HTN Baster T, Baster-Brooks C. Exercise and hypertension. Aust Fam Physician. 2005 Jun;34(6):419-24.
  • 8. Physicalactivity & Exercise  Physical activity (PA) is defined as any bodily movement produced by contraction of skeletal muscles that increases energy expenditure above resting levels and comprises routine daily tasks.  Exercise is a component of physical activity that is planned, structured, and repetitive with the intent of improving or maintaining health.
  • 9. PA,exerciseand preventionof HTN  ↓ Vascular Resistance  ↓ Arterial Stiffness  ↓ Oxidative Stress  ↓ Inflammation  ↓ Body Weight/Body Mass  ↓ Sympathetic Activity  ↓ Renin-angiotensin System Activity  ↓ Intima-media thickness  ↓ Vascular responsiveness to adrenergic- and endothelin- receptor stimulation  ↑ Arterial lumen diameter  ↑ Endothelial Function  ↑ Insulin Sensitivity/Glucose Handling  ↑ Renal Function  ↑ Sodium Handling  ↑ Baroreflex Sensitivity  ↑ Parasympathetic Activity  ↑ Angiogenesis  ↑ Arterial Compliance  ↓ Psychosocial Stress  ↑ Arteriogenesis
  • 10. Antihypertensive effectsof exercise  Aerobic exercise training lowers blood pressure (BP) 5– 7 mmHg, while dynamic resistance training lowers BP 2– 3 mmHg among adults with hypertension.  Exercising as little as 1 day per week is as effective (or even more so) than pharmacotherapy for reducing all- cause mortality among those with hypertension. Baster T, Baster-Brooks C. Exercise and hypertension. Aust Fam Physician. 2005 Jun;34(6):419-24. Brooks JH, Ferro A. The physician's role in prescribing physical activity for the prevention and treatment of essential hypertension. JRSM Cardiovasc Dis. 2012 Jul 31;1(4). pii: cvd.2012.012012.
  • 11. AnExercise Prescriptionfor Hypertension  Frequency: Aerobic exercise on most, preferably all days of the week and dynamic resistance exercise on 2 to 3 days in that same week.  Intensity: Moderate intensity aerobic exercise (i.e., 40 to <60 % VO2max or HR reserve; 11–13 rating of perceived exertion [RPE] on the 6–20 Borg Scale and moderate intensity dynamic resistance exercise (60 % to 80 % one repetition maximum [1-RM]).
  • 12. Time: Aerobic exercise should be performed for 30 to 60 min per day. Dynamic resistance exercise should consist of two to three sets of 10 to 12 repetitions for 8 to 10 exercises that target the major muscle groups of the upper and lower body. The duration of exercise should total 150 min or more per week. Type: Examples of aerobic activities may include walking, jogging, cycling, and swimming. Dynamic resistance training equipment may include machine weights, free weights, and resistance bands, as well as functional body weight exercises.
  • 13.  Endothelial progenitor cells (EPCs) play an important role in repairing vascular injury and can be classified into early and late EPCs.  Late EPCs have been recognized as endogenous cells involved in de novo blood vessel formation. In hypertension, increased peripheral vascular resistance results from vascular dysfunction with MVR (microvascular rarefaction) which is related to late EPC angiogenesis ability.  Exercise is a promising way to increase EPC function, however, the fall in angiogenic capacity of late EPCs is correlated with MVR in hypertension.
  • 14. Medical status Preparticipation screening and physical activity advice 1 Asymptomatic, low CVD risk and BP <140/90 mmHg Routine evaluation and self- directed physical activity 2 Asymptomatic, low CVD risk and hypertensive ≥140/90 mmHg Routine evaluation and begin with moderate intensity exercise (<60% heart rate reserve) 3 Asymptomatic, high CVD risk and hypertensive ≥140/90 mmHg Symptomatic exercise testing prior to start (for example, ECG exercise test) 4 Symptomatic CVD Medical supervision during exercise initially Recommendations regarding exercise testing for individuals with HTN vary depending on their BP level and the presence of other CVD risk factors, target organ disease, or clinical CVD